Fresenius Medical Care AG (FMS) EBITDA Margin (2009 - 2025)
Fresenius Medical Care AG (FMS) recorded quarterly EBITDA Margin of 4926.74% in Q4 2025, up 50406.0% quarter-over-quarter from 9.75% in Q3 2025, and up 492293.0% on a YoY basis from N/an in Q4 2024.
Fresenius Medical Care AG (FMS) EBITDA Margin (2009 - 2025) Analysis & Trends
Fresenius Medical Care AG's EBITDA Margin history runs 17 years deep, the most recent figure standing at 4926.74% for Q4 2025.
- In Q4 2025, EBITDA Margin rose 492293.0% year-over-year to 4926.74%; the TTM figure through Dec 2025 stood at 20.58% (up 1119.0% YoY), while the FY2025 annual figure was 19.04%, down 9.0% from the prior year.
- EBITDA Margin was 4926.74% for Q4 2025 at Fresenius Medical Care AG, up from 9.75% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 5028.75% in Q4 2021 to a low of 0.0% in Q4 2023.
- Historically, EBITDA Margin has averaged 531.77% across 5 years, with a median of 16.95% in 2022.
- The sharpest annual moves came in 2021 and 2022: EBITDA Margin jumped 502875 bps in 2021, then sank 502439 bps in 2022.
- A 5-year view of EBITDA Margin shows it stood at 5028.75% in 2021, then slumped by 100 bps to 4.37% in 2022, then plunged by 100 bps to 0.0% in 2023, then soared by 86607 bps to 3.81% in 2024, then jumped by 129333 bps to 4926.74% in 2025.
- The last three EBITDA Margin figures came in at 4926.74% (Q4 2025), 9.75% (Q3 2025), and 16.72% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn | -2.96% |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn | 24.14% |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn | 14.11% |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn | 3.76% |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn | 8.99% |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn | 11.19% |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn | 4,926.74% |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn | 15.04% |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn | 8.45% |
| 10 | Concentra Group Holdings Parent | 3.59 Bn | 3.54 Bn | 170.47 Mn | 16.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,926.74% |
| Sep 30, 2025 | 9.75% |
| Jun 30, 2025 | 16.72% |
| Mar 31, 2025 | 14.87% |
| Dec 31, 2024 | 3.81% |
| Sep 30, 2024 | 17.39% |
| Jun 30, 2024 | 17.04% |
| Mar 31, 2024 | 16.04% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 15.76% |
| Jun 30, 2023 | 16.39% |
| Mar 31, 2023 | 70.50% |
| Dec 31, 2022 | 4.37% |
| Sep 30, 2022 | 96.08% |
| Jun 30, 2022 | 78.28% |
| Mar 31, 2022 | 16.86% |
| Dec 31, 2021 | 5,028.75% |
| Sep 30, 2021 | 99.48% |
| Jun 30, 2021 | 89.13% |
| Mar 31, 2021 | 97.40% |